Role of transcribed ultraconserved regions in gastric cancer and therapeutic perspectives

World J Gastroenterol. 2022 Jul 7;28(25):2900-2909. doi: 10.3748/wjg.v28.i25.2900.

Abstract

Gastric cancer (GC) is the fourth leading cause of cancer-related death. The occurrence and development of GC is a complex process involving multiple biological mechanisms. Although traditional regulation modulates molecular functions related to the occurrence and development of GC, the comprehensive mechanisms remain unclear. Ultraconserved region (UCR) refers to a genome sequence that is completely conserved in the homologous regions of the human, rat and mouse genomes, with 100% identity, without any insertions or deletions, and often located in fragile sites and tumour-related genes. The transcribed UCR (T-UCR) is transcribed from the UCR and is a new type of long noncoding RNA. Recent studies have found that the expression level of T-UCRs changes during the occurrence and development of GC, revealing a new mechanism underlying GC. Therefore, this article aims to review the relevant research on T-UCRs in GC, as well as the function of T-UCRs and their regulatory role in the occurrence and development of GC, to provide new strategies for GC diagnosis and treatment.

Keywords: Development; Function; Gastric cancer; Therapeutic perspectives; Transcribed ultraconserved region.

Publication types

  • Review

MeSH terms

  • Animals
  • Conserved Sequence / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • RNA, Long Noncoding* / genetics
  • Rats
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / therapy

Substances

  • RNA, Long Noncoding